| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.49M | 48.12M | 49.91M | 52.17M | 53.48M | 51.22M |
| Gross Profit | 29.62M | 30.95M | 29.33M | 31.71M | 31.78M | 30.33M |
| EBITDA | -2.34M | -1.80M | -5.76M | -4.03M | 1.85M | -36.66M |
| Net Income | -4.83M | -4.95M | -9.91M | -8.24M | -4.39M | -38.45M |
Balance Sheet | ||||||
| Total Assets | 41.15M | 43.20M | 47.48M | 56.79M | 65.83M | 76.93M |
| Cash, Cash Equivalents and Short-Term Investments | 10.32M | 12.77M | 14.61M | 20.47M | 27.09M | 33.85M |
| Total Debt | 802.00K | 1.22M | 2.10M | 1.64M | 3.26M | 10.09M |
| Total Liabilities | 9.20M | 10.57M | 11.61M | 12.68M | 14.32M | 24.24M |
| Stockholders Equity | 31.94M | 32.63M | 35.87M | 44.11M | 51.50M | 52.69M |
Cash Flow | ||||||
| Free Cash Flow | -850.00K | -1.53M | -5.77M | -5.16M | -7.69M | -4.73M |
| Operating Cash Flow | -654.00K | -1.10M | -4.39M | -2.29M | -6.34M | -3.37M |
| Investing Cash Flow | -1.06M | -429.00K | -1.31M | -2.87M | -951.00K | 981.00K |
| Financing Cash Flow | -46.00K | -307.00K | -160.00K | -1.46M | 528.00K | -5.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
48 Neutral | $41.74M | -8.73 | -38.21% | ― | 25.10% | 50.62% | |
45 Neutral | $76.43M | -16.17 | -14.61% | ― | -4.32% | -13.99% | |
45 Neutral | $24.10M | ― | -26.62% | ― | -11.07% | 82.06% | |
41 Neutral | $4.60M | ― | ― | ― | -62.46% | -12.90% | |
38 Underperform | $56.99M | -1.47 | -127.41% | ― | -18.94% | 37.05% |
The recent earnings call for Marchex presented a mixed sentiment, balancing both positive achievements and challenges. While the company celebrated strategic advancements, product launches, and a promising acquisition, it also faced a slight revenue decline and anticipated lower performance in the upcoming quarter. Despite these hurdles, Marchex remains optimistic about its future growth and profitability.
Marchex, Inc. is a company specializing in AI and conversational intelligence, providing solutions that enhance operational efficiency and drive revenue growth across various industries. In its latest earnings report, Marchex announced a decrease in GAAP revenue to $11.5 million for the third quarter of 2025, compared to $12.6 million in the same period of 2024. Despite the revenue decline, the company reported an improved adjusted EBITDA of $0.6 million, up from $0.3 million the previous year, highlighting its operational leverage. Additionally, Marchex has entered into an agreement to acquire Archenia, a company focused on AI-driven customer acquisition, which is expected to enhance Marchex’s market reach and strategic capabilities. The acquisition, if completed, could lead to a significant expansion in Marchex’s addressable market and revenue growth potential. Looking ahead, Marchex management remains optimistic about sustainable sales growth and improved EBITDA margins, driven by new product launches and the completion of its technology platform migration.
On November 13, 2025, Marchex announced an agreement in principle to acquire Archenia, Inc., a performance-based customer qualification company, for $10 million in convertible promissory notes. This acquisition aims to create a vertically focused, AI-driven customer acquisition platform, potentially enhancing Marchex’s revenue scale, market reach, and strategic flexibility. Additionally, Marchex reported its third-quarter 2025 financial results, highlighting a decrease in GAAP revenue to $11.5 million compared to the previous year, but an improvement in adjusted EBITDA to $1.1 million. The company is optimistic about its future growth prospects, anticipating a 10% revenue growth in 2026 due to its ongoing product launches and technology platform migration.
The most recent analyst rating on (MCHX) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Marchex stock, see the MCHX Stock Forecast page.
On September 16, 2025, Marchex announced significant changes to its executive team, with CEO Edwin Miller stepping down to become a senior advisor, and new appointments including Troy Hartless as President, Francis Feeney as Chief Operating Officer, and Brian Nagle as Chief Financial Officer. These changes are part of Marchex’s strategic evolution towards growth, leveraging its expanding AI product portfolio to enhance customer penetration and market reach, positioning the company for future growth and increased operational efficiencies.
The most recent analyst rating on (MCHX) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Marchex stock, see the MCHX Stock Forecast page.